Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Via Giustiniani 3, 35128, Padua, Italy.
Fondazione Citta' Della Speranza, Istituto Di Ricerca Pediatrica, Via Ricerca Scientifica, 4, 35127, Padua, Italy.
J Clin Immunol. 2022 Feb;42(2):299-311. doi: 10.1007/s10875-021-01159-4. Epub 2021 Oct 31.
Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.
慢性肉芽肿病(CGD)是一种罕见的先天性免疫缺陷病(IEI),其特征是吞噬细胞杀伤能力缺陷,由于吞噬体中的 NADPH 氧化酶无法产生活性氧物质。CGD 患者会遭受严重且反复的感染和慢性炎症性疾病。CGD 在新生儿中的发病极为罕见,仅见于个案报道或小病例系列。我们在此报告了来自两个不同家系的 3 名新生儿病例,他们表现出与 CGD 相关的新型感染和炎症表型。一名 CYBA 缺陷的女孩表现为坏死性肺炎,需要长时间的抗生素治疗,导致肺纤维化改变。来自第二个家系的两名男孩中,老大患致命性伯克霍尔德菌多重感染,于 24 日龄时死亡。他的弟弟被诊断为 CYBB 缺陷,并患有巨噬细胞活化综合征/噬血细胞性淋巴组织细胞增生症(MAS/HLH),但没有任何感染,类固醇治疗可控制病情。我们进一步报告了文献复习的结果,并表明 CGD 新生儿感染的微生物谱与年长患者相似,但临床表现更为多样,特别是与炎症综合征相关的临床表现。我们的发现扩展了 CGD 的临床表现谱,包括不常见的新生儿表型。早期、潜在危及生命的 CGD 表现的识别对于及时诊断、提高生存率和降低长期后遗症风险至关重要。